首页 > 最新文献

International Journal of Care Pathways最新文献

英文 中文
An integrated care pathway for Guillain–Barré syndrome in children 儿童格林-巴罗综合征的综合护理途径
Pub Date : 2010-06-01 DOI: 10.1258/jicp.2010.010005
B. Lakin, E. White, R. Appleton
Integrated care pathways are widely used for a range of medical and surgical conditions with the aim of providing a streamlined and unified approach to evidence-based care. They have been used for a number of years in the multidisciplinary management of adults with neurological conditions who are expected to require prolonged rehabilitation. Care pathways have been used in approximately 60 conditions at Alder Hey Children's Hospital over the past few years. This paper describes an experience of a care pathway for children with Guillain–Barré syndrome. As far as the authors are aware, this is the first care pathway to be used for children with a neurological disorder. Preliminary observations, which have yet to be formally audited, suggest that the pathway has benefited patient care and significantly improved patient documentation and interdisciplinary communication. It has also helped to reduce and minimize unnecessary variation from expected evidence-based management.
综合护理途径广泛用于一系列医疗和外科条件,目的是为循证护理提供简化和统一的方法。他们已经使用了多年的多学科管理与神经系统疾病的成人谁预计需要长期康复。在过去几年中,Alder Hey儿童医院在大约60种情况下使用了护理路径。本文描述了一个护理途径的经验与格林-巴-罗综合征的儿童。据作者所知,这是第一个用于患有神经系统疾病的儿童的护理途径。初步观察,尚未正式审计,表明该途径有利于病人护理和显著改善病人的文件和跨学科的沟通。它还有助于减少和最大限度地减少预期的循证管理的不必要变化。
{"title":"An integrated care pathway for Guillain–Barré syndrome in children","authors":"B. Lakin, E. White, R. Appleton","doi":"10.1258/jicp.2010.010005","DOIUrl":"https://doi.org/10.1258/jicp.2010.010005","url":null,"abstract":"Integrated care pathways are widely used for a range of medical and surgical conditions with the aim of providing a streamlined and unified approach to evidence-based care. They have been used for a number of years in the multidisciplinary management of adults with neurological conditions who are expected to require prolonged rehabilitation. Care pathways have been used in approximately 60 conditions at Alder Hey Children's Hospital over the past few years. This paper describes an experience of a care pathway for children with Guillain–Barré syndrome. As far as the authors are aware, this is the first care pathway to be used for children with a neurological disorder. Preliminary observations, which have yet to be formally audited, suggest that the pathway has benefited patient care and significantly improved patient documentation and interdisciplinary communication. It has also helped to reduce and minimize unnecessary variation from expected evidence-based management.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"19 11-12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116699707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Why the pharmaceutical industry is interested in research on care pathways 为什么制药行业对护理途径的研究感兴趣
Pub Date : 2010-06-01 DOI: 10.1258/JICP.2010.010018
Dirk Blyweert
The pharmaceutical company Pfizer is supporting an international study on care pathways, being carried out by the European Pathway Association. Over the last few years, this pharmaceutical company has spent a substantial amount of money to make this study on care pathways possible. This international research as well as the contribution of Pfizer Belgium, also counts on the support of Pfizer Ireland, Portugal and Italy. Pfizer Belgium directors Kris Westelinck (Managing Director) and Peter Menu (Director Public Affairs and Policy) elucidate their plans, together with KU Leuven Professor Arthur Vleugels during an interview by Dirk Blyweert (independent journalist).
辉瑞制药公司正在支持一项由欧洲途径协会开展的关于护理途径的国际研究。在过去的几年里,这家制药公司花了大量的钱来研究护理途径。这项国际研究以及辉瑞比利时公司的贡献,也依靠辉瑞爱尔兰,葡萄牙和意大利的支持。辉瑞比利时公司董事克里斯·韦斯特林克(总经理)和彼得·梅努克(公共事务和政策总监)在接受独立记者德克·布利维特采访时,与鲁汶大学教授亚瑟·弗莱格斯一起阐明了他们的计划。
{"title":"Why the pharmaceutical industry is interested in research on care pathways","authors":"Dirk Blyweert","doi":"10.1258/JICP.2010.010018","DOIUrl":"https://doi.org/10.1258/JICP.2010.010018","url":null,"abstract":"The pharmaceutical company Pfizer is supporting an international study on care pathways, being carried out by the European Pathway Association. Over the last few years, this pharmaceutical company has spent a substantial amount of money to make this study on care pathways possible. This international research as well as the contribution of Pfizer Belgium, also counts on the support of Pfizer Ireland, Portugal and Italy. Pfizer Belgium directors Kris Westelinck (Managing Director) and Peter Menu (Director Public Affairs and Policy) elucidate their plans, together with KU Leuven Professor Arthur Vleugels during an interview by Dirk Blyweert (independent journalist).","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128986640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The European Quality of Care Pathway (EQCP) Study: history, project management and approach 欧洲护理质量途径(EQCP)研究:历史、项目管理和方法
Pub Date : 2010-06-01 DOI: 10.1258/jicp.2010.010015
K. Vanhaecht, W. Sermeus, J. Peers, S. Deneckere, C. Lodewijckx, F. Leigheb, M. Panella
The European Quality of Care Pathway (EQCP) study is the first, international, cluster randomized controlled trial launched to study the effect of the implementation of care pathways and to study why and under what circumstances pathways work. The study will be performed in Belgium, Italy, Ireland and Portugal and will include individual studies: a trial including chronic obstructive pulmonary disease patients, a trial including proximal femur fracture patients and a trial focusing on multidisciplinary teamwork within both populations. The study is managed by the European Pathway Association in close collaboration with a multidisciplinary team of the Catholic University Leuven (Belgium), the University of Eastern Piedmont (Italy), the National School of Public Health Lisbon (Portugal) and the Health Services Executive in Dublin (Ireland). This paper will describe the history, project management and overall approach of this international study.
欧洲护理质量途径(EQCP)研究是第一个国际性的集群随机对照试验,旨在研究实施护理途径的效果,并研究途径为何有效以及在什么情况下有效。该研究将在比利时、意大利、爱尔兰和葡萄牙进行,并将包括个别研究:一项试验包括慢性阻塞性肺病患者,一项试验包括股骨近端骨折患者,一项试验侧重于两种人群中的多学科团队合作。这项研究由欧洲途径协会与天主教鲁汶大学(比利时)、东皮埃蒙特大学(意大利)、里斯本国家公共卫生学院(葡萄牙)和都柏林卫生服务执行局(爱尔兰)的一个多学科小组密切合作管理。本文将描述这一国际研究的历史、项目管理和总体方法。
{"title":"The European Quality of Care Pathway (EQCP) Study: history, project management and approach","authors":"K. Vanhaecht, W. Sermeus, J. Peers, S. Deneckere, C. Lodewijckx, F. Leigheb, M. Panella","doi":"10.1258/jicp.2010.010015","DOIUrl":"https://doi.org/10.1258/jicp.2010.010015","url":null,"abstract":"The European Quality of Care Pathway (EQCP) study is the first, international, cluster randomized controlled trial launched to study the effect of the implementation of care pathways and to study why and under what circumstances pathways work. The study will be performed in Belgium, Italy, Ireland and Portugal and will include individual studies: a trial including chronic obstructive pulmonary disease patients, a trial including proximal femur fracture patients and a trial focusing on multidisciplinary teamwork within both populations. The study is managed by the European Pathway Association in close collaboration with a multidisciplinary team of the Catholic University Leuven (Belgium), the University of Eastern Piedmont (Italy), the National School of Public Health Lisbon (Portugal) and the Health Services Executive in Dublin (Ireland). This paper will describe the history, project management and overall approach of this international study.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115445192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Frontotemporal dementias: development of an integrated care pathway through an experiential survey of patients and carers 额颞叶痴呆:通过对患者和护理人员的经验调查的综合护理途径的发展
Pub Date : 2010-06-01 DOI: 10.1258/jicp.2010.010010
M. Davies, A. Larner
The frontotemporal lobar degenerations (FTLDs) constitute one form of neurodegenerative dementia, which presents with behavioural or linguistic symptoms which often elude precise diagnosis in the early stages of disease, to the frustration of both patients and carers. Based on experiential data from patients and carers seen in both the voluntary care sector (the Alzheimer's Society) and a dedicated Cognitive Function Clinic over periods of 3 to 4 years, a provisional integrated care pathway for FTLDs has been developed which seeks to ensure timely diagnosis and access to appropriate care needs.
额颞叶变性(FTLDs)是神经退行性痴呆的一种形式,其表现为行为或语言症状,在疾病的早期阶段往往难以准确诊断,使患者和护理人员都感到沮丧。根据自愿护理部门(阿尔茨海默氏症协会)和专门的认知功能诊所在3至4年期间从患者和护理人员那里获得的经验数据,已经为FTLDs制定了一个临时综合护理途径,旨在确保及时诊断并获得适当的护理需求。
{"title":"Frontotemporal dementias: development of an integrated care pathway through an experiential survey of patients and carers","authors":"M. Davies, A. Larner","doi":"10.1258/jicp.2010.010010","DOIUrl":"https://doi.org/10.1258/jicp.2010.010010","url":null,"abstract":"The frontotemporal lobar degenerations (FTLDs) constitute one form of neurodegenerative dementia, which presents with behavioural or linguistic symptoms which often elude precise diagnosis in the early stages of disease, to the frustration of both patients and carers. Based on experiential data from patients and carers seen in both the voluntary care sector (the Alzheimer's Society) and a dedicated Cognitive Function Clinic over periods of 3 to 4 years, a provisional integrated care pathway for FTLDs has been developed which seeks to ensure timely diagnosis and access to appropriate care needs.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122480395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The experience of conducting a Cochrane systematic review of the impact of clinical pathways on professional practice, patient outcomes, length of stay and hospital costs 对临床路径对专业实践、患者预后、住院时间和医院费用的影响进行Cochrane系统评价的经验
Pub Date : 2009-11-01 DOI: 10.1258/jicp.2009.009009
T. Rotter, L. Kinsman, E. James, A. Machotta, H. Gothe, J. Kugler
Despite the high prevalence of clinical pathways (CPWs), the results from published studies are inconsistent and contradictory. The plethora of study designs, settings and lack of an agreed definition of a CPW make the relevance of individual studies difficult to apply to clinical settings. It was timely to catalogue and analyse the existing evidence base for CPWs via a rigorous systematic review. Systematic reviews and meta-analyses provide a high level of evidence for the effectiveness of interventions and are commonly employed reviewing strategies for addressing scientific questions in health-related research. This method is especially useful when research results are known to be inconsistent. Instead of conducting another primary evaluation, a detailed review is needed that reflects a summation of available research. This paper reports and discusses methodological and technical issues of a systematic review of the effectiveness of CPWs in hospitals, based on our experience with the Cochrane Effective Practice and Organisation of Care Group.
尽管临床途径(cpw)的流行率很高,但已发表的研究结果不一致且相互矛盾。过多的研究设计、设置和缺乏一致的CPW定义使得个体研究的相关性难以应用于临床设置。通过严格的系统审查,及时对CPWs的现有证据进行编目和分析。系统评价和荟萃分析为干预措施的有效性提供了高水平的证据,是解决健康相关研究中科学问题的常用评价策略。这种方法在研究结果不一致的情况下特别有用。与其进行另一次初步评估,不如进行一次详细的审查,以反映现有研究的总结。本文根据我们在Cochrane有效实践和护理组织小组的经验,报告并讨论了对医院CPWs有效性的系统评价的方法和技术问题。
{"title":"The experience of conducting a Cochrane systematic review of the impact of clinical pathways on professional practice, patient outcomes, length of stay and hospital costs","authors":"T. Rotter, L. Kinsman, E. James, A. Machotta, H. Gothe, J. Kugler","doi":"10.1258/jicp.2009.009009","DOIUrl":"https://doi.org/10.1258/jicp.2009.009009","url":null,"abstract":"Despite the high prevalence of clinical pathways (CPWs), the results from published studies are inconsistent and contradictory. The plethora of study designs, settings and lack of an agreed definition of a CPW make the relevance of individual studies difficult to apply to clinical settings. It was timely to catalogue and analyse the existing evidence base for CPWs via a rigorous systematic review. Systematic reviews and meta-analyses provide a high level of evidence for the effectiveness of interventions and are commonly employed reviewing strategies for addressing scientific questions in health-related research. This method is especially useful when research results are known to be inconsistent. Instead of conducting another primary evaluation, a detailed review is needed that reflects a summation of available research. This paper reports and discusses methodological and technical issues of a systematic review of the effectiveness of CPWs in hospitals, based on our experience with the Cochrane Effective Practice and Organisation of Care Group.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121931437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Do we need electronic support for pathways: the Spanish experience 我们是否需要电子支持路径:西班牙的经验
Pub Date : 2009-11-01 DOI: 10.1258/jicp.2009.009010
Ricard Rosique
Care pathways are excellent tools for quality management in health care concerning the standardization of care processes, as they promote organized and efficient patient care established on evidence-based practice. The implementation of a care pathway project at any health-care setting means a change of the organizational culture. E-pathways (electronic pathways) are strategic resources in order to get the successful implementation of a care pathway project. The concept of e-pathway is recent enough and there are some different experiences worldwide. In 2000, the first electronic pathways were implemented at Hospital de Mataró, in Barcelona, Spain. The benefits of using e-pathways (Eira Healthcare Server) are very clear at Hospital de Mataró: immediate records with no transcriptions, information in the palm of your hand, no prints, and rigour and reliability. Another recent and interesting experience is the development and introduction of e-pathways at Hospital General de l'Hospitalet, in Barcelona, Spain, using an SAP integrated health-care solution. The strategy planning of hospital managers should take into account the need and priority of any pathway project linked to e-pathways. Some experiences in Spain have proven that we do really need electronic support for pathways. Electronic pathways are a basic support and should not be postponed when implementing care pathways.
护理路径是医疗保健质量管理的优秀工具,涉及到护理过程的标准化,因为它们促进了基于循证实践的有组织和有效的患者护理。在任何卫生保健机构实施护理途径项目意味着改变组织文化。e路径(电子路径)是成功实施护理路径项目的战略资源。电子通道的概念是最近才出现的,世界范围内有一些不同的经验。2000年,西班牙巴塞罗那的Mataró医院实施了第一个电子通道。使用e-pathways (Eira医疗保健服务器)的好处在Hospital de Mataró非常明显:即时记录,无需转录,信息在您的手掌上,无需打印,以及严格和可靠。最近的另一个有趣的经验是,西班牙巴塞罗那的hospitalet总医院使用SAP集成医疗保健解决方案开发和引入了电子通道。医院管理者的战略规划应考虑到与电子途径相关的任何途径项目的需要和优先次序。西班牙的一些经验证明,我们确实需要电子途径的支持。电子途径是一种基本支持,在实施护理途径时不应推迟。
{"title":"Do we need electronic support for pathways: the Spanish experience","authors":"Ricard Rosique","doi":"10.1258/jicp.2009.009010","DOIUrl":"https://doi.org/10.1258/jicp.2009.009010","url":null,"abstract":"Care pathways are excellent tools for quality management in health care concerning the standardization of care processes, as they promote organized and efficient patient care established on evidence-based practice. The implementation of a care pathway project at any health-care setting means a change of the organizational culture. E-pathways (electronic pathways) are strategic resources in order to get the successful implementation of a care pathway project. The concept of e-pathway is recent enough and there are some different experiences worldwide. In 2000, the first electronic pathways were implemented at Hospital de Mataró, in Barcelona, Spain. The benefits of using e-pathways (Eira Healthcare Server) are very clear at Hospital de Mataró: immediate records with no transcriptions, information in the palm of your hand, no prints, and rigour and reliability. Another recent and interesting experience is the development and introduction of e-pathways at Hospital General de l'Hospitalet, in Barcelona, Spain, using an SAP integrated health-care solution. The strategy planning of hospital managers should take into account the need and priority of any pathway project linked to e-pathways. Some experiences in Spain have proven that we do really need electronic support for pathways. Electronic pathways are a basic support and should not be postponed when implementing care pathways.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114433339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Is there a future for pathways? Five pieces of the puzzle 路径有未来吗?拼图的五个部分
Pub Date : 2009-11-01 DOI: 10.1258/jicp.2009.009013
K. Vanhaecht, M. Panella, R. van Zelm, W. Sermeus
In this discussion and opinion paper, the Bureau members of the European Pathway Association present five challenges for the future of care pathways. Pathways will have to be based on the latest available evidence and international databases, and tools will have to be available. If pathways have a future, the organisations should focus on disease-specific oriented care. Evidence-based pathways, which are organised in a disease-specific oriented organisation, can lead to improvement of quality and efficiency but only if we invest in real teamwork. As a fourth challenge, the need for technical support of pathways is presented. The last piece of the future pathway puzzle is the need for patient involvement. Pathways will only lead to continuous improvement if we finally see patients as real partners in care organisation.
在这份讨论和意见文件中,欧洲路径协会的主席团成员提出了护理路径未来面临的五大挑战。途径必须以现有的最新证据和国际数据库为基础,而且必须有可用的工具。如果路径有未来,这些组织应该把重点放在针对特定疾病的护理上。在以疾病为导向的组织中组织的循证途径可以提高质量和效率,但前提是我们投资于真正的团队合作。作为第四个挑战,提出了对路径技术支持的需求。未来通路之谜的最后一块是需要患者参与。只有当我们最终将患者视为护理组织中真正的合作伙伴时,途径才会导致持续的改进。
{"title":"Is there a future for pathways? Five pieces of the puzzle","authors":"K. Vanhaecht, M. Panella, R. van Zelm, W. Sermeus","doi":"10.1258/jicp.2009.009013","DOIUrl":"https://doi.org/10.1258/jicp.2009.009013","url":null,"abstract":"In this discussion and opinion paper, the Bureau members of the European Pathway Association present five challenges for the future of care pathways. Pathways will have to be based on the latest available evidence and international databases, and tools will have to be available. If pathways have a future, the organisations should focus on disease-specific oriented care. Evidence-based pathways, which are organised in a disease-specific oriented organisation, can lead to improvement of quality and efficiency but only if we invest in real teamwork. As a fourth challenge, the need for technical support of pathways is presented. The last piece of the future pathway puzzle is the need for patient involvement. Pathways will only lead to continuous improvement if we finally see patients as real partners in care organisation.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"32 2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123224938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 40
ICPAT: Integrated Care Pathways Appraisal Tool 综合护理途径评估工具
Pub Date : 2009-11-01 DOI: 10.1258/jicp.2009.009012
Claire L Whittle
This report outlines how the Integrated Care Pathways Appraisal Tool (ICPAT) has been applied in the assessment of the content and quality of a selection of integrated care pathways in use in the United Kingdom.
本报告概述了综合护理路径评估工具(ICPAT)如何应用于评估英国使用的综合护理路径选择的内容和质量。
{"title":"ICPAT: Integrated Care Pathways Appraisal Tool","authors":"Claire L Whittle","doi":"10.1258/jicp.2009.009012","DOIUrl":"https://doi.org/10.1258/jicp.2009.009012","url":null,"abstract":"This report outlines how the Integrated Care Pathways Appraisal Tool (ICPAT) has been applied in the assessment of the content and quality of a selection of integrated care pathways in use in the United Kingdom.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121898262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Care pathways: from clinical pathways to care innovation 护理路径:从临床路径到护理创新
Pub Date : 2009-11-01 DOI: 10.1258/JICP.2009.009014
M. Panella, K. Vanhaecht, W. Sermeus
This is the first issue of the International Journal of Care Pathways (IJCP) that has been edited by the European Pathway Association team. The European Pathway Association (ivzw) is an international not-for-profit association. The goal of our association is to perform international research, to organize international knowledge sharing, to support international collaboration and to advise policy-makers on care pathways. Therefore, in this issue, we have decided to focus on presenting different international experiences on care pathways inside and outside Europe. The articles in this issue of the IJCP originate from a conference that took place on 28 May 2009 in Leuven, Belgium, held to mark 10 years of care pathways in Belgium. The conference was a landmark in showing that the developments in care pathways, although still quite recent, are growing fast. Kathy Bower, principal and co-owner of the Center for Case Management in the USA, was one of the first keynote speakers, and talked about the very first beginnings of care pathways, 25 years ago, in the New England Medical Center (now Tufts Medical Center) in 1984. Their origin coincided with the onset of Diagnosis Related Groups (DRGs) in the USA as a method of cost-containment. DRGs were used to define homogeneous patient groups for which a prospective payment rate was set. It forced managers and clinicians to start organizing the care they were providing. In Belgium, research on care pathways began in 1996, mainly based on the experiences in the USA and in the meantime also in the UK. It was the basis for launching the Belgian–Dutch Clinical Pathway Network (www.nkp. be) in March 1999. The Network was defined as a knowledge-sharing network between academia and health-care facilities. The aim of the Network was to improve the effectiveness of developing, implementing and evaluating care pathways. The Network started with eight corporate members (all hospitals). In 2009, the number of members increased to up to more than 100 health-care organizations, broadening the scope from hospitals to home care organizations, rehabilitation centres and mental health organizations. The number of care pathways that are in development or up and running in these organizations has grown to more than 1000 different projects. The top of this list is led by conditions with a high predictive flow of care such as total hip and knee arthroplasty and normal delivery. But the list of conditions for which care pathways have been built is long and varies from simple to complex procedures, and high to low predictability. About 9% of all care pathways are crossing the boundary of their own organization, mainly in bridging the continuum between primary and secondary care. The Network in 2000 was mainly focusing on Flemish acute hospital care. As there was interest from the Netherlands and French-speaking Belgian hospitals, the Network looked for collaboration with the Dutch Institute for Quality improvement and the Université
这是由欧洲途径协会团队编辑的《国际护理途径杂志》(IJCP)的第一期。欧洲途径协会(ivzw)是一个国际非营利性协会。我们协会的目标是开展国际研究,组织国际知识共享,支持国际合作,并就护理途径向决策者提供建议。因此,在本期中,我们决定重点介绍欧洲内外关于护理途径的不同国际经验。本期IJCP的文章源于2009年5月28日在比利时鲁汶举行的一次会议,该会议是为纪念比利时护理途径10周年而举行的。这次会议是一个里程碑,表明护理途径的发展,尽管仍然是最近才出现的,但正在迅速发展。Kathy Bower,美国病例管理中心的负责人和共同所有人,是第一批主讲人之一,她在25年前的1984年在新英格兰医学中心(现在的塔夫茨医学中心)谈到了护理途径的最初开始。它们的起源与美国作为成本控制方法的诊断相关组(DRGs)的开始相吻合。DRGs用于定义同质患者组,并为其设定预期支付率。它迫使管理人员和临床医生开始组织他们所提供的护理。比利时对护理路径的研究始于1996年,主要借鉴了美国的经验,同时也借鉴了英国的经验。它是启动比利时-荷兰临床途径网络(www.nkp)的基础。1999年3月。该网络被定义为学术界与卫生保健机构之间的知识共享网络。该网络的目的是提高制定、实施和评估护理途径的有效性。该网络最初有8个公司成员(都是医院)。2009年,成员数量增加到100多个保健组织,范围从医院扩大到家庭护理组织、康复中心和精神健康组织。在这些组织中,正在开发或正在运行的护理途径的数量已经增长到1000多个不同的项目。排在这一榜单首位的是具有高预测流程的护理条件,如全髋关节和膝关节置换术和正常分娩。但是,已经建立的护理途径的条件清单很长,从简单到复杂的程序,从高到低的可预测性各不相同。在所有护理途径中,约有9%跨越了其所在组织的边界,主要是在初级和二级保健之间架起桥梁。2000年,该网络主要侧重于佛兰德急症医院护理。由于荷兰和讲法语的比利时医院有兴趣,该网络分别寻求与荷兰质量改进研究所和鲁汶天主教大学合作,作为荷兰和比利时法语地区的护理途径促进中心。2004年,欧洲途径协会(www.E-P-A.org)成立,为国际合作开辟了道路。2009年5月的鲁汶会议计划展示的正是这条比利时和国际的历史路线,因为在过去的10年里,道路取得了令人难以置信的发展。与此同时,从早期开始,实际的护理途径对他们的亲属来说不再熟悉。虽然护理路径的首要目标是控制成本,但实际的重点是质量和安全。成本效益几乎已经成为组织良好的护理的副产品。其主要目的是提供正确的护理,以满足患者的需要。虽然早期的护理途径非常注重将一个团队聚集在一起并加强沟通和协调,但新的护理途径侧重于将指南和循证护理结合起来。护理途径越来越被视为跨学科团队如何将指导方针付诸实践的一种手段。护理路径方法认识到跨学科团队,通常从几个到100多个成员不等,将有相同的重点,在那里讨论和设置角色,讨论沟通渠道,最重要的是,他们坚持相同的循证标准。会议期间,德国-澳大利亚Cochrane研究小组的研究员兼负责人托马斯·罗特(Thomas Rotter)首次概述了他们的工作成果。Massimiliano Panella是Piemonte Orientale ' Amedeo Avogadro大学的公共卫生教授,也是欧洲途径协会的主席,他在这期的论文中展示了设计良好的途径的效果,这种途径是基于最先进的死亡率和患者结果的证据而建立的。 早期护理途径被写在纸上,这有时会给卫生专业人员带来更多的行政负担。未来的新途径将是数字化的。它们将需要统一的数字平台、通信和文件标准,以及在患者记录和临床文件系统中整合护理途径,以确定访问权限。西班牙B-Braun医疗部门的负责人Ricard Rosique在本期的论文中展示了这些数字系统是如何设计和工作的。早期的路径通过定义团队成员的角色来组织护理,但是如果这些安排被付诸实践,它仍然高度依赖于个人专业人员。这些途径并没有嵌入系统中。新的护理途径将把这些组织安排编码到系统中,例如调度和工作流程系统。马丁·艾略特教授,儿科医生
{"title":"Care pathways: from clinical pathways to care innovation","authors":"M. Panella, K. Vanhaecht, W. Sermeus","doi":"10.1258/JICP.2009.009014","DOIUrl":"https://doi.org/10.1258/JICP.2009.009014","url":null,"abstract":"This is the first issue of the International Journal of Care Pathways (IJCP) that has been edited by the European Pathway Association team. The European Pathway Association (ivzw) is an international not-for-profit association. The goal of our association is to perform international research, to organize international knowledge sharing, to support international collaboration and to advise policy-makers on care pathways. Therefore, in this issue, we have decided to focus on presenting different international experiences on care pathways inside and outside Europe. The articles in this issue of the IJCP originate from a conference that took place on 28 May 2009 in Leuven, Belgium, held to mark 10 years of care pathways in Belgium. The conference was a landmark in showing that the developments in care pathways, although still quite recent, are growing fast. Kathy Bower, principal and co-owner of the Center for Case Management in the USA, was one of the first keynote speakers, and talked about the very first beginnings of care pathways, 25 years ago, in the New England Medical Center (now Tufts Medical Center) in 1984. Their origin coincided with the onset of Diagnosis Related Groups (DRGs) in the USA as a method of cost-containment. DRGs were used to define homogeneous patient groups for which a prospective payment rate was set. It forced managers and clinicians to start organizing the care they were providing. In Belgium, research on care pathways began in 1996, mainly based on the experiences in the USA and in the meantime also in the UK. It was the basis for launching the Belgian–Dutch Clinical Pathway Network (www.nkp. be) in March 1999. The Network was defined as a knowledge-sharing network between academia and health-care facilities. The aim of the Network was to improve the effectiveness of developing, implementing and evaluating care pathways. The Network started with eight corporate members (all hospitals). In 2009, the number of members increased to up to more than 100 health-care organizations, broadening the scope from hospitals to home care organizations, rehabilitation centres and mental health organizations. The number of care pathways that are in development or up and running in these organizations has grown to more than 1000 different projects. The top of this list is led by conditions with a high predictive flow of care such as total hip and knee arthroplasty and normal delivery. But the list of conditions for which care pathways have been built is long and varies from simple to complex procedures, and high to low predictability. About 9% of all care pathways are crossing the boundary of their own organization, mainly in bridging the continuum between primary and secondary care. The Network in 2000 was mainly focusing on Flemish acute hospital care. As there was interest from the Netherlands and French-speaking Belgian hospitals, the Network looked for collaboration with the Dutch Institute for Quality improvement and the Université","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125784329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Continuous quality improvement in care of the dying with the Liverpool Care Pathway for the Dying Patient 通过利物浦临终病人护理途径持续提高临终病人护理质量
Pub Date : 2009-11-01 DOI: 10.1258/jicp.2009.009011
M. Gambles, T. McGlinchey, J. Aldridge, D. Murphy, J. Ellershaw
In order to illustrate the usefulness of a continuous quality improvement approach in care of the dying, this paper focuses on the process and outcomes of the first National Care of the Dying Audit in Hospitals in England. One hundred and eighteen individual hospitals delivering care to patients in the last hours and days of their lives using the Liverpool Care Pathway for the Dying Patient participated in the audit and provided 2672 patient datasets. The results illustrate both that important information can be gained about care delivery using this method and that the opportunity to engage in formal and collaborative reflection, discussion and action planning is useful in promoting continuous quality improvement. This process is likely not only to be of interest to clinicians working in the field but also to managers and planners striving to ensure continuous quality improvement for patients and carers and to inform the process of benchmarking for the future.
为了说明一个持续的质量改进方法在护理死亡的有用性,本文着重于过程和结果的第一个国家护理的死亡审计在英国医院。118家使用利物浦临终病人护理路径为病人提供生命最后几小时和几天的护理的医院参与了审计,并提供了2672个病人数据集。结果表明,使用这种方法可以获得关于护理提供的重要信息,并且有机会参与正式和协作的反思,讨论和行动计划,这对于促进持续的质量改进是有用的。这一过程可能不仅对在该领域工作的临床医生感兴趣,而且对努力确保患者和护理人员持续质量改进的管理人员和计划人员也感兴趣,并为未来的基准过程提供信息。
{"title":"Continuous quality improvement in care of the dying with the Liverpool Care Pathway for the Dying Patient","authors":"M. Gambles, T. McGlinchey, J. Aldridge, D. Murphy, J. Ellershaw","doi":"10.1258/jicp.2009.009011","DOIUrl":"https://doi.org/10.1258/jicp.2009.009011","url":null,"abstract":"In order to illustrate the usefulness of a continuous quality improvement approach in care of the dying, this paper focuses on the process and outcomes of the first National Care of the Dying Audit in Hospitals in England. One hundred and eighteen individual hospitals delivering care to patients in the last hours and days of their lives using the Liverpool Care Pathway for the Dying Patient participated in the audit and provided 2672 patient datasets. The results illustrate both that important information can be gained about care delivery using this method and that the opportunity to engage in formal and collaborative reflection, discussion and action planning is useful in promoting continuous quality improvement. This process is likely not only to be of interest to clinicians working in the field but also to managers and planners striving to ensure continuous quality improvement for patients and carers and to inform the process of benchmarking for the future.","PeriodicalId":114083,"journal":{"name":"International Journal of Care Pathways","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132783563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
期刊
International Journal of Care Pathways
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1